Global Live Vaccines Market Research Report 2023

Report ID: 1891959 | Published Date: Oct 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Live Vaccines Market Overview
    1.1 Product Overview and Scope of Live Vaccines
    1.2 Live Vaccines Segment by Type
        1.2.1 Global Live Vaccines Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Monovalent Live Vaccines
        1.2.3 Multivalent Live Vaccines
    1.3 Live Vaccines Segment by Application
        1.3.1 Global Live Vaccines Sales Comparison by Application: (2022-2028)
        1.3.2 Adults
        1.3.3 Children
    1.4 Global Live Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Live Vaccines Revenue 2017-2028
        1.4.2 Global Live Vaccines Sales 2017-2028
        1.4.3 Live Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Live Vaccines Market Competition by Manufacturers
    2.1 Global Live Vaccines Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Live Vaccines Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Live Vaccines Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Live Vaccines Manufacturing Sites, Area Served, Product Type
    2.5 Live Vaccines Market Competitive Situation and Trends
        2.5.1 Live Vaccines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Live Vaccines Players Market Share by Revenue
        2.5.3 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Live Vaccines Retrospective Market Scenario by Region
    3.1 Global Live Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Live Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Live Vaccines Market Facts & Figures by Country
        3.3.1 North America Live Vaccines Sales by Country
        3.3.2 North America Live Vaccines Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Live Vaccines Market Facts & Figures by Country
        3.4.1 Europe Live Vaccines Sales by Country
        3.4.2 Europe Live Vaccines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Live Vaccines Market Facts & Figures by Region
        3.5.1 Asia Pacific Live Vaccines Sales by Region
        3.5.2 Asia Pacific Live Vaccines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Live Vaccines Market Facts & Figures by Country
        3.6.1 Latin America Live Vaccines Sales by Country
        3.6.2 Latin America Live Vaccines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Live Vaccines Market Facts & Figures by Country
        3.7.1 Middle East and Africa Live Vaccines Sales by Country
        3.7.2 Middle East and Africa Live Vaccines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Live Vaccines Historic Market Analysis by Type
    4.1 Global Live Vaccines Sales Market Share by Type (2017-2022)
    4.2 Global Live Vaccines Revenue Market Share by Type (2017-2022)
    4.3 Global Live Vaccines Price by Type (2017-2022)
5 Global Live Vaccines Historic Market Analysis by Application
    5.1 Global Live Vaccines Sales Market Share by Application (2017-2022)
    5.2 Global Live Vaccines Revenue Market Share by Application (2017-2022)
    5.3 Global Live Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Live Vaccines Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 GlaxoSmithKline
        6.2.1 GlaxoSmithKline Corporation Information
        6.2.2 GlaxoSmithKline Description and Business Overview
        6.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GlaxoSmithKline Live Vaccines Product Portfolio
        6.2.5 GlaxoSmithKline Recent Developments/Updates
    6.3 Pfizer
        6.3.1 Pfizer Corporation Information
        6.3.2 Pfizer Description and Business Overview
        6.3.3 Pfizer Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Pfizer Live Vaccines Product Portfolio
        6.3.5 Pfizer Recent Developments/Updates
    6.4 Novartis
        6.4.1 Novartis Corporation Information
        6.4.2 Novartis Description and Business Overview
        6.4.3 Novartis Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Novartis Live Vaccines Product Portfolio
        6.4.5 Novartis Recent Developments/Updates
    6.5 Astellas Pharma
        6.5.1 Astellas Pharma Corporation Information
        6.5.2 Astellas Pharma Description and Business Overview
        6.5.3 Astellas Pharma Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Astellas Pharma Live Vaccines Product Portfolio
        6.5.5 Astellas Pharma Recent Developments/Updates
    6.6 Emergent BioSolutions
        6.6.1 Emergent BioSolutions Corporation Information
        6.6.2 Emergent BioSolutions Description and Business Overview
        6.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Emergent BioSolutions Live Vaccines Product Portfolio
        6.6.5 Emergent BioSolutions Recent Developments/Updates
    6.7 AstraZeneca
        6.6.1 AstraZeneca Corporation Information
        6.6.2 AstraZeneca Description and Business Overview
        6.6.3 AstraZeneca Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 AstraZeneca Live Vaccines Product Portfolio
        6.7.5 AstraZeneca Recent Developments/Updates
7 Live Vaccines Manufacturing Cost Analysis
    7.1 Live Vaccines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Live Vaccines
    7.4 Live Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Live Vaccines Distributors List
    8.3 Live Vaccines Customers
9 Live Vaccines Market Dynamics
    9.1 Live Vaccines Industry Trends
    9.2 Live Vaccines Market Drivers
    9.3 Live Vaccines Market Challenges
    9.4 Live Vaccines Market Restraints
10 Global Market Forecast
    10.1 Live Vaccines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Live Vaccines by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Live Vaccines by Type (2023-2028)
    10.2 Live Vaccines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Live Vaccines by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Live Vaccines by Application (2023-2028)
    10.3 Live Vaccines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Live Vaccines by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Live Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Live Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Doses) & (US$ Million)
    Table 2. Global Live Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Doses) & (US$ Million)
    Table 3. Global Live Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Live Vaccines Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Live Vaccines Sales (K Doses) of Key Manufacturers (2017-2022)
    Table 6. Global Live Vaccines Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Live Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Live Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Live Vaccines Average Price (USD/Dose) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Live Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers Live Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Live Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Vaccines as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Live Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 16. Global Live Vaccines Sales Market Share by Region (2017-2022)
    Table 17. Global Live Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Live Vaccines Revenue Market Share by Region (2017-2022)
    Table 19. North America Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 20. North America Live Vaccines Sales Market Share by Country (2017-2022)
    Table 21. North America Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Live Vaccines Revenue Market Share by Country (2017-2022)
    Table 23. Europe Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 24. Europe Live Vaccines Sales Market Share by Country (2017-2022)
    Table 25. Europe Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Live Vaccines Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Live Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 28. Asia Pacific Live Vaccines Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Live Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Live Vaccines Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 32. Latin America Live Vaccines Sales Market Share by Country (2017-2022)
    Table 33. Latin America Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Live Vaccines Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Live Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 36. Middle East and Africa Live Vaccines Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Live Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Live Vaccines Revenue Market Share by Country (2017-2022)
    Table 39. Global Live Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 40. Global Live Vaccines Sales Market Share by Type (2017-2022)
    Table 41. Global Live Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Live Vaccines Revenue Share by Type (2017-2022)
    Table 43. Global Live Vaccines Price by Type (2017-2022) & (USD/Dose)
    Table 44. Global Live Vaccines Sales (K Doses) by Application (2017-2022)
    Table 45. Global Live Vaccines Sales Market Share by Application (2017-2022)
    Table 46. Global Live Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Live Vaccines Revenue Share by Application (2017-2022)
    Table 48. Global Live Vaccines Price by Application (2017-2022) & (USD/Dose)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 52. Merck Live Vaccines Product
    Table 53. Merck Recent Developments/Updates
    Table 54. GlaxoSmithKline Corporation Information
    Table 55. GlaxoSmithKline Description and Business Overview
    Table 56. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 57. GlaxoSmithKline Live Vaccines Product
    Table 58. GlaxoSmithKline Recent Developments/Updates
    Table 59. Pfizer Corporation Information
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 62. Pfizer Live Vaccines Product
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Novartis Corporation Information
    Table 65. Novartis Description and Business Overview
    Table 66. Novartis Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 67. Novartis Live Vaccines Product
    Table 68. Novartis Recent Developments/Updates
    Table 69. Astellas Pharma Corporation Information
    Table 70. Astellas Pharma Description and Business Overview
    Table 71. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 72. Astellas Pharma Live Vaccines Product
    Table 73. Astellas Pharma Recent Developments/Updates
    Table 74. Emergent BioSolutions Corporation Information
    Table 75. Emergent BioSolutions Description and Business Overview
    Table 76. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 77. Emergent BioSolutions Live Vaccines Product
    Table 78. Emergent BioSolutions Recent Developments/Updates
    Table 79. AstraZeneca Corporation Information
    Table 80. AstraZeneca Description and Business Overview
    Table 81. AstraZeneca Live Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 82. AstraZeneca Live Vaccines Product
    Table 83. AstraZeneca Recent Developments/Updates
    Table 84. Production Base and Market Concentration Rate of Raw Material
    Table 85. Key Suppliers of Raw Materials
    Table 86. Live Vaccines Distributors List
    Table 87. Live Vaccines Customers List
    Table 88. Live Vaccines Market Trends
    Table 89. Live Vaccines Market Drivers
    Table 90. Live Vaccines Market Challenges
    Table 91. Live Vaccines Market Restraints
    Table 92. Global Live Vaccines Sales Forecast by Type (2023-2028) & (K Doses)
    Table 93. Global Live Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 94. Global Live Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 95. Global Live Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 96. Global Live Vaccines Sales Forecast by Application (2023-2028) & (K Doses)
    Table 97. Global Live Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 98. Global Live Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 99. Global Live Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 100. Global Live Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
    Table 101. Global Live Vaccines Sales Market Share Forecast by Region (2023-2028)
    Table 102. Global Live Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 103. Global Live Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Live Vaccines
    Figure 2. Global Live Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Monovalent Live Vaccines Product Picture
    Figure 4. Multivalent Live Vaccines Product Picture
    Figure 5. Global Live Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Adults
    Figure 7. Children
    Figure 8. Global Live Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Live Vaccines Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Live Vaccines Sales (2017-2028) & (K Doses)
    Figure 11. Live Vaccines Sales Share by Manufacturers in 2021
    Figure 12. Global Live Vaccines Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Live Vaccines Players: Market Share by Revenue in 2021
    Figure 14. Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Live Vaccines Sales Market Share by Region (2017-2022)
    Figure 16. Global Live Vaccines Sales Market Share by Region in 2021
    Figure 17. Global Live Vaccines Revenue Market Share by Region (2017-2022)
    Figure 18. Global Live Vaccines Revenue Market Share by Region in 2021
    Figure 19. U.S. Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Taiwan Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Philippines Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Vietnam Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. U.A.E Live Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Live Vaccines by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Live Vaccines
    Figure 45. Manufacturing Process Analysis of Live Vaccines
    Figure 46. Live Vaccines Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
GlaxoSmithKline
Pfizer
Novartis
Astellas Pharma
Emergent BioSolutions
AstraZeneca
Frequently Asked Questions
Live Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Live Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Live Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Inflammatory Marker

Inflammatory Marker market is segmented by players, region (country), by Type and by Application. ... Read More

Suture Tape

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Valve Cover Gasket

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More